Nine out of 10 business leaders expect growth in profit and revenue, but also expect increased capital expenditure and higher credit, a survey of 300 top corporate executives showed.
Vijay Kedia buys 9 lakh shares of SME stock Mahamaya Lifesciences in Rs 12.5 crore block deal
Ace investor Vijay Kedia acquired a significant stake in Mahamaya Lifesciences through a block deal. He purchased nearly 9 lakh shares at Rs 140 each.